{"id":"palmitoleic-acid-infliximab","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection (bacterial, fungal, tuberculosis)"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Lupus-like syndrome"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Palmitoleic acid is a monounsaturated fatty acid that promotes alternative macrophage activation and reduces pro-inflammatory cytokine production. When combined with infliximab (a TNF-α neutralizing monoclonal antibody), it may potentiate immunosuppressive effects and improve clinical outcomes in inflammatory conditions by synergistic reduction of TNF-α signaling and enhanced resolution of inflammation.","oneSentence":"Palmitoleic acid enhances the anti-inflammatory effects of infliximab, a TNF-α inhibitor, by modulating immune cell function and reducing systemic inflammation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:59:35.789Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Inflammatory bowel disease (Crohn's disease, ulcerative colitis)"}]},"trialDetails":[{"nctId":"NCT07417696","phase":"PHASE4","title":"Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"Chinese Medical Association","startDate":"2026-04-01","conditions":"Crohn's Disease","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Palmitoleic Acid + Infliximab","genericName":"Palmitoleic Acid + Infliximab","companyName":"Chinese Medical Association","companyId":"chinese-medical-association","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Palmitoleic acid enhances the anti-inflammatory effects of infliximab, a TNF-α inhibitor, by modulating immune cell function and reducing systemic inflammation. Used for Rheumatoid arthritis, Inflammatory bowel disease (Crohn's disease, ulcerative colitis).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}